India Platelet Rich Plasma for Chronic Pain Management Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Indication (Tendonitis, Arthritis, Tennis Elbow, Knee Injury, Shoulder Injury, Torn Ligaments, Shoulder Injury, Migraine and Chronic Headache, and Neck and Back Injury)

Market Introduction

The platelet rich plasma therapy involves the use of local injections of the patient’s own concentrated platelets that helps to accelerate the healing of muscles, ligaments, tendons, and joints. The platelet rich plasma (PRP) has the potential to regenerate the tissues, thereby decreasing pain through the effect of bioactive molecules and growth factors that are present in alpha granules. The success of PRP therapy depends on the method of preparation, composition of PRP, medical condition of patients, and type of tissue wherein PRP is injected.

Market Overview and Dynamics

The India platelet rich plasma for chronic pain management market is expected to reach US$ 5,932.43 thousand by 2027 from US$ 2,437.50 thousand in 2019; it is anticipated to grow at a CAGR of 12.1% from 2020 to 2027. Factors driving the market growth include rise in number of musculoskeletal diseases andincrease in geriatric population. Whereas, the market is likely to have negative impact due to alternatives for chronic pain management coupled with poor doctor to patient ratio.

Key Market Segments

By indication, the arthritis segment held the largest share of the market in 2019. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the major primary and secondary sources referred to while preparing the report on the India platelet rich plasma for chronic pain management market are Indian Orthopedic Association, Indian Council of Medical Research, and Organization for Economic Co-operation and Development.

Reasons to Buy report

• To understand the India platelet rich plasma for chronic pain management market landscape and identifymarket segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for India platelet rich plasma for chronic pain management market
• Efficiently plan M&A and partnership dealsin India platelet rich plasma for chronic pain management market by identifying market segments with the most promising probable sales
• Helps to takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form India platelet rich plasma for chronic pain management market
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in India .

India Platelet Rich Plasma for Chronic Pain Management Market

By Indication

• Arthritis
• Knee injuries
• Shoulder injuries
• Tendonitis
• Torn ligaments
• Neck and back injuries
• Tennis elbow
• Migraines and chronic headaches

Company Profiles

• Tricell Bio
• Remi Group
• Alchem Diagnostics
• Regencare
• Regenexx
• Niw Surgicals
• Zances Medical Technology
• Quantum Biomedicals
• Biobase
• Levaram Lifescience

The List of Companies - India Platelet Rich Plasma for Chronic Pain Management Market

1. Tricell Bio
2. Remi Group
3. Alchem Diagnostics
4. Regencare
5. Regenexx
6. Niw Surgicals
7. Zances Medical Technology
8. Quantum Biomedicals
9. Biobase
10. Levram Lifescience

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the India platelet rich plasma for chronic pain management.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the India wound irrigation solutions market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.